NASDAQ: IPHA
Innate Pharma Sa Stock Ownership - Who owns Innate Pharma Sa?

Insider buying vs selling

Have Innate Pharma Sa insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when IPHA insiders and whales buy or sell their stock.

IPHA Shareholders

What type of owners hold Innate Pharma Sa stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Lion Point Capital LP0.00%81$167.67Institution
Liopoi0.00%81$167.67Institution
Morsta0.00%44$91.08Institution
Morgan Stanley0.00%44$91.08Institution
Smartharvest Portfolios LLC0.00%24$49.68Institution
Smapor0.00%24$49.68Institution
Xtx Topco Ltd0.00%15$31.05Institution
Xtxtop0.00%15$31.05Institution
Citadel Advisors LLC0.00%12$24.84Institution
Citade0.00%12$24.84Institution

1 of 2

IPHA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
IPHA0.00%0.00%
KRRO0.04%99.96%Net BuyingNet Selling
CRBP0.07%76.95%Net SellingNet Selling
ABOS0.07%15.71%Net BuyingNet Selling
ORMP0.04%53.95%Net SellingNet Selling

Innate Pharma Sa Stock Ownership FAQ

Who owns Innate Pharma Sa?

Innate Pharma Sa (NASDAQ: IPHA) is owned by 0.00% institutional shareholders, 0.00% Innate Pharma Sa insiders, and 100.00% retail investors. Lion Point Capital LP is the largest individual Innate Pharma Sa shareholder, owning 81.00 shares representing 0.00% of the company. Lion Point Capital LP's Innate Pharma Sa shares are currently valued at $167.67.

If you're new to stock investing, here's how to buy Innate Pharma Sa stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.